PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half

Large, multi-center registry provides surprising alternative to current standard of care following TAVR for all patients, even those with coronary artery disease

2025-05-01
(Press-News.org) Washington, D.C. – MAY 1, 2025 – Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after transcatheter aortic valve replacement (TAVR) is associated with a significantly lower incidence of six-month mortality and major bleeding risk compared to dual antiplatelet therapy (DAPT). The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.

The current standard of care following TAVR is SAPT, which involves the use of only one antiplatelet drug, such as aspirin, to prevent blood clot formation. Traditionally, SAPT is used compared to DAPT, mainly based on the lower bleeding risk; however, the data on mortality are inconclusive. This insight is increasingly important as the number of TAVR procedures performed has steadily increased, making it the most common procedure for patients with aortic stenosis.

Researchers analyzed real-world data from the multicenter TRITAVI registry to determine the differing therapies’ effect on mortality. 5,514 patients (81.5+6.8 years, 48.4% males) were discharged either on SAPT (n=3,197) or DAPT (n=2,317). 

The all-cause mortality and rate of major bleeding at six months were significantly lower in the SAPT group as compared with the DAPT group (2.4% vs 5.4%, and 0.5% vs. 1.3%, respectively). SAPT was associated with lower cardiovascular and non-cardiovascular mortality, as compared to DAPT (1.3% vs 2.2% and 1.1% vs 3.2%, respectively). Sensitivity analyses confirmed that DAPT was significantly associated with mortality both in men (adjusted HR: 2.08; 95% CI: 1.32-3.30) and in women (adjusted HR: 1.53; 95% CI: 1.03-2.29), as well as in patients with coronary artery disease (CAD) (adjusted HR: 1.83; 95% CI: 1.01-3.35) and in patients without CAD (adjusted HR: 1.52; 95% CI: 1.04-2.20). 

“We were surprised to find that SAPT, rather than DAPT, after TAVR is associated with a better outcome, even in patients with CAD,” said Francesco Pelliccia, MD, PhD, Associate Professor of Cardiology at Sapienza University in Rome, Italy, and lead author of the study. “The results, for the first time, provide clinicians more information on how to treat their patients who are at high risk for bleeding and provide evidence that SAPT should be considered the standard of care in all patients undergoing TAVR. 

 

Session Details:

“Antiplatelet Therapy and All-cause Mortality after Transcatheter Aortic Valve Replacement – Insights from the TRITAVI Registry”

Thursday, May 1, 2025; 10:47-10:55 AM ET

Walter E. Washington Convention Center, Exhibit Hall D

###
 

About Society for Cardiovascular Angiography & Interventions (SCAI)

The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 5,000 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit https://scai.org/. 

For more information about the SCAI 2025 Scientific Sessions, visit https://scai.org/scai-2025-scientific-sessions. Follow @SCAI on X for the latest heart health news and use #SCAI2025 to follow the latest discussions.

END



ELSE PRESS RELEASES FROM THIS DATE:

Women and Black patients face higher risks and unequal access in advanced cardiovascular procedures

2025-05-01
Press Contacts: Gavin Stern gstern@scai.org, 202-644-8561 Annika Parrish  aparrish@brgcommunications.com, 703-793-8356    WOMEN AND BLACK PATIENTS FACE HIGHER RISKS AND UNEQUAL ACCESS IN ADVANCED CARDIOVASCULAR PROCEDURES   Women Experience Higher Risk of Serious Cardiovascular Events After Transcatheter Aortic Valve Implantation and Left Atrial Appendage Occlusion Device Placement Black Patients with Chronic Limb-Threatening Ischemia Almost 50% More Likely to Require Major Amputation Yet 10% ...

In iron-dependent cell death, lysosome destabilization is key

2025-05-01
Fukuoka, Japan—The duplication and division of cells is critical to keeping all multicellular organisms alive. But the opposite process is equally important: cell death. Controlled death of cells, or programmed cell death, is also necessary for the proper development and function of the body. It has also been a focus of researchers developing treatments for cancer by finding ways to activate the cell death of cancer cells themselves. Ferroptosis is a recently discovered form of programmed cell death and has been a promising target for the ...

Stenting improves long-term survival for patients with complete blockages undergoing percutaneous coronary intervention

2025-05-01
Washington, D.C. – MAY 1, 2025 – In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. Coronary artery disease (CAD) is the most common type of heart disease and a leading cause of death worldwide. CTO PCI is a minimally invasive procedure to treat CAD by reopening blocked arteries with a catheter and stent. CTO PCI is a ...

Nationwide study finds ambulatory surgery centers treat 15% more patients in socially vulnerable areas for cardiac interventions

2025-05-01
Washington, D.C. – MAY 1, 2025 – The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse event rates at 30 days, compared to outpatient hospital departments, but were less likely to use certain technologies. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. Ambulatory surgery centers (ASCs) are non-hospital facilities that provide same-day surgical or procedural ...

Intestinal depletion of TM6SF2 exacerbates high-fat diet-induced metabolic dysfunction-associated steatotic liver disease through the gut-liver axis

2025-05-01
Background and Aims Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide. This study aimed to explore the role of TM6SF2 in high-fat diet (HFD)-induced MASLD through the gut-liver axis. Methods The TM6SF2 gut-specific knockout (TM6SF2 GKO) mouse was constructed using CRISPR/Cas9 technology. TM6SF2 GKO and wild-type (CON) mice were fed either a HFD or a control diet for 16 weeks to induce MASLD. Blood, liver, and intestinal lipid content, as well as gut microbiota and serum metabolites, were then analyzed. Results TM6SF2 GKO ...

New research shows one in four patients in early cardiogenic shock experience poorer outcomes

2025-05-01
Washington, D.C. – MAY 1, 2025 – In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, or in-hospital mortality. The data were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. CS is a life-threatening condition in which the heart cannot pump enough blood to meet the body’s needs. As a result, your blood pressure may suddenly drop to dangerous levels, and if CS isn’t diagnosed and treated ...

Clinical trial underway for potential Long COVID treatment

2025-05-01
FORT LAUDERDALE, Fla. — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced today.  With funding from SILC, NSU researchers led by Dr. Nancy Klimas are enrolling 100 patients in the multi-year study with the goal of improving their Long Covid symptoms and restoring them to full health.   “Like ...

STEM students: Work hard, but don’t compare yourself to others

2025-05-01
COLUMBUS, Ohio – A new study shows how damaging it can be for college students in introductory STEM classes to compare how hard they work to the extent of effort put in by their peers.   Researchers studied students in an introductory chemistry class, one of the STEM (Science, Technology, Engineering and Mathematics) fields. They found that those who thought they had to work harder than others in class were less likely to believe they had the ability to succeed in science.   This focus on comparative effort was bad for both men and women in the class. But women showed positive effects of thinking they tried hard in the class ...

Neuroestrogen: The brain’s secret weapon against hunger

2025-05-01
For years, estrogens were known as the reproductive hormones produced by the ovaries, but recent discoveries reveal that these hormones are also synthesized in the brain through an enzyme called aromatase. This brain-specific version of estrogen is called neuroestrogen, and while its presence has been known, its precise function remained unclear—until now. Researchers from Fujita Health University reveal a groundbreaking discovery suggesting the direct role of neuroestrogen in appetite regulation. “It is well known that MC4R (melanocortin-4 receptor) is an important receptor in the brain that regulates food intake,” explains lead author Takanori Hayashi, Associate Professor ...

Detecting Parkinson's disease with a simple retinal exam

2025-05-01
Could it be possible to diagnose Parkinson's disease with the help of a simple retinal exam? The idea should be seriously considered, according to a study published in the May issue of Neurobiology of Disease by researchers from Université Laval who discovered that the retina of people with Parkinson's disease responds differently to light stimuli than that of healthy people. Parkinson's disease is usually diagnosed when a person consults a doctor because of motor problems such as tremors. “By then, the disease has been present for several ...

LAST 30 PRESS RELEASES:

GLP-1 studies add to growing body of evidence demonstrating significant benefit on cardiovascular outcomes

Alarming rise in cardiovascular deaths for those with obesity disproportionately impacting minorities and women

Rhythmically trained sea lion returns for an encore—and performs as well as humans

Study of facial bacteria could lead to probiotics that promote healthy skin

Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer

Designer microbe shows promise for reducing mercury absorption from seafood

Sex- and race-specific prevalence of hearing loss across the adult lifespan and associated factors

Ptero firma: Footprints pinpoint when ancient flying reptiles conquered the ground

New research from Mass General Brigham guides treatment regimen for aggressive blood cancer

USC team develops a powerful new analytical tool to advance CAR T cell therapy research

Boosting NAD+ levels slows aging in cells from Werner syndrome patients

JMIR Rehabilitation and Assistive Technologies invites submissions on advancing telerehabilitation research and innovation

Seven stroke advocates recognized nationwide for resilience and community impact

The National Multiple Sclerosis Society commits over $18 million for research to drive pathways to cures

Virtual pulmonary rehabilitation programs are safe, effective for people with COPD

Good karma for me, bad karma for you

Studies underscore occupational health hazards for Cath lab personnel and highlight need for lead-less solutions

Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half

Women and Black patients face higher risks and unequal access in advanced cardiovascular procedures

In iron-dependent cell death, lysosome destabilization is key

Stenting improves long-term survival for patients with complete blockages undergoing percutaneous coronary intervention

Nationwide study finds ambulatory surgery centers treat 15% more patients in socially vulnerable areas for cardiac interventions

Intestinal depletion of TM6SF2 exacerbates high-fat diet-induced metabolic dysfunction-associated steatotic liver disease through the gut-liver axis

New research shows one in four patients in early cardiogenic shock experience poorer outcomes

Clinical trial underway for potential Long COVID treatment

STEM students: Work hard, but don’t compare yourself to others

Neuroestrogen: The brain’s secret weapon against hunger

Detecting Parkinson's disease with a simple retinal exam

Study opens the door for stronger evidence in bomb handling cases

Guided VR meditations can reduce anxiety for parents of hospitalized children

[Press-News.org] Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half
Large, multi-center registry provides surprising alternative to current standard of care following TAVR for all patients, even those with coronary artery disease